In a recent study, neuroleptic-naive patients showed lower prefrontal D1R availability compared to healthy control subjects revealed by PET, suggesting a reduction of prefrontal D1R density in the pathophysiology of schizophrenia [70]. The gene discussed is DRD1; the disease is schizophrenia.